Prescient Therapeutics Ltd (PTX) — Cash Flow Reinvestment Rate

Latest as of June 2013: 0.00x

Prescient Therapeutics Ltd (PTX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2013, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$32.65K. Check Prescient Therapeutics Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

AU$0.00

Capex + Investments

Operating Cash Flow

AU$32.65K

AUD

Capital Expenditures

AU$0.00

AUD

Prescient Therapeutics Ltd Cash Flow Reinvestment Rate (1991–1993)

Historical reinvestment intensity for Prescient Therapeutics Ltd across 2 annual periods. Explore Prescient Therapeutics Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Prescient Therapeutics Ltd (1991–1993)

Year-by-year capital reinvestment analysis for Prescient Therapeutics Ltd. For live market cap and broader valuation context, see market value of Prescient Therapeutics Ltd.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
1993	0.32x	AU$562.00K	AU$1.74 Million	AU$562.00K	▼ -12.3%
1991	0.37x	AU$269.00K	AU$730.00K	AU$269.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow